Tag Archives: Marketing

Indian Government Proposes Ban on Physician Gifts

By Ben Comer | Published: June 6, 2011
India’s Department of Pharmaceuticals released a 14-page “voluntary code” for drug marketers, which includes a strict ban on gifts to prescribers, among other things. The code, which is open for public comment until June 30th, states that “no gifts, pecuniary advantages or benefits in kind may be supplied, offered or promised to persons qualified to prescribe” [...]
Posted in Advertising, Emerging Markets, Global, Marketing, Medical Education, Strategy | Also tagged , , , , , | Leave a comment

Justice to Pharma: "Do the Perp Walk!"

By Walter Armstrong | Published: November 17, 2010
Former GSK counsel is the first target in government’s executive-liability crackdown. Could J&J be next? The US Department of Justice filed criminal charges last week against Lauren Stevens, a former VP and assistant general counsel at GlaxoSmithKline. Going after pharma execs marks a seismic shift in the government’s efforts to stem the tide of fraud and [...]
Posted in Legal, Strategy | Also tagged , , , , | 4 Comments

Marketing: A Digital Disconnect

By Julian Upton | Published: October 6, 2010
Peter Houston is concerned that pharma is taking too long getting to grips with digital marketing. I was at the 2nd European DigiPharm conference in London last week. I didn’t manage the whole two days, but what I did see left me a little concerned that pharma is still struggling with digital marketing. This is not a [...]
Posted in E-Media, Europe, Global, Guest Blog, Technology, social media | Also tagged , , | 1 Comment

Big Pharma Reps Still Competing with Local Players in Emerging Markets

By Reid Paul | Published: September 15, 2010
Although pharma is an increasingly global marketplace, the relative rankings of companies are becoming more localized — with significant variations — according to a new Cegedim survey of physician attitudes towards reps in the major western markets and Brazil, India, Russia, and China. According to the International Rep Quality survey, physicians tend to favor domestic [...]
Posted in Emerging Markets, Europe, Guest Blog, Marketing, Sales | Also tagged , , , , , | Leave a comment

Baxter Receives Third FDA Warning for Misleading Promotional Material

By Julian Upton | Published: September 1, 2010
FDA issued a warning letter to Baxter International for making “misleading efficacy claims” about its lung drug Araplast NP, which is contraindicated in individuals with selective IgA deficiencies and prescribed to patients who are at increased risk of emphysema. FDA’s letter, dated Aug. 3, takes issue with claims in a brochure aimed at physicians that [...]
Posted in FDA | Also tagged , , , , | Leave a comment